Apellis Pharmaceuticals, Inc.
APLS
$41.06
$0.040.10%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 406.20M | 467.79M | 480.23M | 374.78M | 362.34M |
| Total Receivables | 445.11M | 369.16M | 354.64M | 229.23M | 244.38M |
| Inventory | 133.61M | 144.76M | 123.79M | 121.24M | 93.83M |
| Prepaid Expenses | 17.38M | 9.52M | 10.43M | 13.47M | 16.14M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 25.72M | 23.62M | 21.59M | 16.90M | 11.04M |
| Total Current Assets | 1.03B | 1.01B | 990.68M | 755.61M | 727.72M |
|
|
|||||
| Total Current Assets | 1.03B | 1.01B | 990.68M | 755.61M | 727.72M |
| Net Property, Plant & Equipment | 20.36M | 19.90M | 21.65M | 16.75M | 17.77M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 34.15M | 40.51M | 46.40M | 49.03M | 61.80M |
| Total Assets | 1.08B | 1.08B | 1.06B | 821.39M | 807.29M |
|
|
|||||
| Total Accounts Payable | 49.05M | 56.80M | 38.60M | 54.24M | 55.29M |
| Total Accrued Expenses | 133.69M | 166.05M | 140.32M | 139.00M | 116.15M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 100.71M | 100.75M | 100.60M | 7.42M | 6.94M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 283.45M | 323.60M | 279.53M | 200.66M | 178.38M |
|
|
|||||
| Total Current Liabilities | 283.45M | 323.60M | 279.53M | 200.66M | 178.38M |
| Long-Term Debt | 362.24M | 361.66M | 361.09M | 454.04M | 453.42M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 12.81M | 11.95M | 13.68M | 8.31M | 9.19M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.11M | 7.90M | 3.26M | 2.08M | 2.08M |
| Total Liabilities | 667.61M | 705.11M | 657.56M | 665.09M | 643.07M |
|
|
|||||
| Common Stock & APIC | 3.41B | 3.39B | 3.36B | 3.33B | 3.29B |
| Retained Earnings | -2.99B | -3.01B | -2.95B | -3.17B | -3.13B |
| Treasury Stock & Other | -2.41M | -2.10M | -2.40M | -2.57M | -3.05M |
| Total Common Equity | 414.92M | 370.15M | 401.17M | 156.31M | 164.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 414.92M | 370.15M | 401.17M | 156.31M | 164.22M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 414.92M | 370.15M | 401.17M | 156.31M | 164.22M |
|
|
|||||